US3075975A - Anthelmintic distilbazoles and method - Google Patents

Anthelmintic distilbazoles and method Download PDF

Info

Publication number
US3075975A
US3075975A US115996A US11599661A US3075975A US 3075975 A US3075975 A US 3075975A US 115996 A US115996 A US 115996A US 11599661 A US11599661 A US 11599661A US 3075975 A US3075975 A US 3075975A
Authority
US
United States
Prior art keywords
compounds
lutidine
bis
anthelmintic
distilbazoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US115996A
Other languages
English (en)
Inventor
Arthur P Phillips
Robert B Burrows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Burroughs Wellcome Co USA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL277327D priority Critical patent/NL277327A/xx
Priority claimed from US104798A external-priority patent/US3085935A/en
Application filed by Burroughs Wellcome Co USA filed Critical Burroughs Wellcome Co USA
Priority to US115996A priority patent/US3075975A/en
Priority to GB22626/61A priority patent/GB1009301A/en
Priority to DE19621470413 priority patent/DE1470413A1/de
Priority to CH480662A priority patent/CH413836A/de
Priority to ES276612A priority patent/ES276612A1/es
Priority to DK179562AA priority patent/DK104234C/da
Priority to LU41596D priority patent/LU41596A1/xx
Priority to BR138334/62A priority patent/BR6238334D0/pt
Priority to FR895385A priority patent/FR1320520A/fr
Priority to SE451262A priority patent/SE217920C1/xx
Priority to FR895386A priority patent/FR1841M/fr
Publication of US3075975A publication Critical patent/US3075975A/en
Application granted granted Critical
Priority to OA52810A priority patent/OA02352A/xx
Priority to MY196793A priority patent/MY6700093A/xx
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/14Styryl dyes

Definitions

  • This parasite (Eêtrobius vermicularz's) is the most common nematode parasite of the human inhabitants of North America and Europe. It is particularly common among young children and frequently spreads through a family. Since it dwells in the lower intestine, it is difficult to eradicate. At the same time, while it is a nuisance and shocking to the sensibilities of many people, it is not usually dangerous and serious effects upon the host have not been clearly demonstrated.
  • the invention comprises a novel group of distilbazole compounds of the preceding formula and the administration of these compounds in the treatment of nematode infestations, particulary human pin-worms.
  • Table I are shown the result of tests with illustrative compounds of this invention and of three close relatives, first in regard to toxicity (LD in mice and secondly in eliminating the pin-worm of mice, Syphacia obvelata. (This parasite has been found in past experience to be of particular value as vectors which indicate drugs useful against the human pin-worm.) It will be seen that the first three compounds of the table, having dimethylamino or diethylamino groups on the benzene rings have LD values of 2535 mg./kg. while high efficiency against pinworms requires /3 to /2 of that amount.
  • the six following compounds are active at about the same level, but have an entirely different order of toxicity (LD being over 1000 mg./kg. in four of the six cases). All of these compounds were administered as iodides wherefore differences in molecular weights were negligible as regards relative toxicity.
  • n o om solvents the usual metathetical conversions of anions (e.g. that of an iodide to a chloride by treatment with silver chloride) are rather unsatisfactory. It is consequently convenient to have as the anion of the lutidine quaternary salt that anion which is desired in the product. Again, conveniently, the anion may be that introduced by the alkyiating agent.
  • the anion may be that introduced by the alkyiating agent.
  • alkylation of 2,6-lutidine with propyl p-toluenesulfonate aflfords 2,6- dimethyl-l-propylpyridiniurn tosylate which is then condensed with p-pyrrolidinobenzaldehyde or p-piperidinobenzaldehyde to give 2,6-bis-p-pyrrolidino or piperidino styrylpyridine n-propyl tosylate.
  • metathetical interconversions are readily accomplished at this stage so that to make a Compound II where X is chloride, it is easy to convert 2,6- lutidine methiodide to the metho-chloride by warming with methanolic hydrogen chloride.
  • the compounds '11 are dark-colored crystals whose surface color ranges from dark red to almost black.
  • EXAMPLE 1 Preparations .dissolved in 200 cc. of methanol and hydrogen chloride gas was run in until 20 g. had been absorbed. The solution was then warmed on the steam bath, most of the solvent being gradually distilled out. One hundred cc. of 10% methanolic hydrogen chloride was then added and the process repeated. Finally the flask was evacurated on the steam bath. The rather hydroscopic residue was the etho-chloride of 2,6-lutidine and was suitable for synthetic purposes without further manipulation.
  • N-phenylpyrr'oIidine A mixture of 216 g. of 1,4-dibromobutane, 500 cc. of methanol and 465 g. of aniline was refluxed for 5 hours at 100 C. Methanol was evaporated and 120 g. of sodium hydroxide (as 40-50% aqueous solution) was added to the residue. The organic layer was taken up in ether and dried over anhydrous 4, potassium carbonate. After removing potassium carbonate and ether the excess aniline was distilled in vacuo and saved, and the product was collected. N-phenylpyrrolidine boiled at 133-134 C. at 19 mm.; the yield was 130 g. (88-90%).
  • mice Single Percent Mice dose worms cleared] mgjkg. removed Mice dosed 48-236 (CHmN H1 25 20 100 /5 1.5 100 5/5 97 7/13 5 92 2/13 2.5 51 0/6 61-2 (CHmN ch 35 100 3/3 10 97 5/9 7.5 92 1/6 5 86 2/6 2.5 69 1/6 60-434 (C1H3)2N- CH3 20 99 4/5 10 99 4/5 5 67 1/12 61-31 N CH3 1 000 20 96 3/6 10 92 2 6 5 so 2/6 61-32 N Cm: 1,350 2g 13g a 6 2/3 61-75 N CHZCHZCHS.
  • R X- wherein n has the values of 2 and 3, R is selected from 2,534,237 Cusic Dec. 19, 1950 the class consisting of the methyl, ethyl and n-propyl 2,890,982 Natt June 16, 1959 groups, and X- is an anion derived from a pharmaceutically acceptable acid.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
US115996A 1961-04-24 1961-06-07 Anthelmintic distilbazoles and method Expired - Lifetime US3075975A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NL277327D NL277327A (de) 1961-04-24
US115996A US3075975A (en) 1961-04-24 1961-06-07 Anthelmintic distilbazoles and method
GB22626/61A GB1009301A (en) 1961-04-24 1961-12-22 Styryl-pyridinium compounds, the preparation thereof, and pharmaceutical compositions thereof
DE19621470413 DE1470413A1 (de) 1961-04-24 1962-04-16 Quaternaere Ammoniumverbindungen,deren Herstellung und pharmazeutische Zubereitungen
CH480662A CH413836A (de) 1961-04-24 1962-04-18 Verfahren zur Herstellung von Distilbazolen
ES276612A ES276612A1 (es) 1961-04-24 1962-04-18 Un método para la preparación de compuestos de diestilzabol
DK179562AA DK104234C (da) 1961-04-24 1962-04-18 Fremgangsmåde til fremstilling af distilbazolforbindelser.
LU41596D LU41596A1 (de) 1961-04-24 1962-04-21
BR138334/62A BR6238334D0 (pt) 1961-04-24 1962-04-23 Um processo para a preparacao de compostos do cation distilbazol
FR895385A FR1320520A (fr) 1961-04-24 1962-04-24 Sels quaternaires de dérivés du distilbazole
SE451262A SE217920C1 (de) 1961-04-24 1962-04-24
FR895386A FR1841M (fr) 1961-04-24 1962-04-24 Médicament a base d'un sel quaternaire dérivé du distilbazole.
OA52810A OA02352A (fr) 1961-04-24 1967-03-11 Sels quaternaires de dérivés du distibazole.
MY196793A MY6700093A (en) 1961-04-24 1967-12-31 Styryl-pyridium compounds, the preparation thereof, and pharmaceutical compositions thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US104798A US3085935A (en) 1961-04-24 1961-04-24 Method for the elimination of nematode infestations
US115996A US3075975A (en) 1961-04-24 1961-06-07 Anthelmintic distilbazoles and method

Publications (1)

Publication Number Publication Date
US3075975A true US3075975A (en) 1963-01-29

Family

ID=26801948

Family Applications (1)

Application Number Title Priority Date Filing Date
US115996A Expired - Lifetime US3075975A (en) 1961-04-24 1961-06-07 Anthelmintic distilbazoles and method

Country Status (13)

Country Link
US (1) US3075975A (de)
BR (1) BR6238334D0 (de)
CH (1) CH413836A (de)
DE (1) DE1470413A1 (de)
DK (1) DK104234C (de)
ES (1) ES276612A1 (de)
FR (1) FR1841M (de)
GB (1) GB1009301A (de)
LU (1) LU41596A1 (de)
MY (1) MY6700093A (de)
NL (1) NL277327A (de)
OA (1) OA02352A (de)
SE (1) SE217920C1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
WO2004078136A3 (en) * 2003-03-03 2004-12-16 Mycosol Inc Pyridinium salts, compounds and methods of use
WO2007056556A3 (en) * 2005-11-08 2007-10-25 Mycosol Inc Polyethylene glycol conjugates of pyridinium and thiazolium compounds and methods of using the same
US20130281392A1 (en) * 2012-04-20 2013-10-24 Merial Limited Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1994170A (en) * 1930-09-20 1935-03-12 Agfa Ansco Corp Compound of the distyryl pyridinium salt series and its production
US2534237A (en) * 1950-12-19 B-haloxanthine salts of aminoalkyl
GB656515A (en) * 1947-04-02 1951-08-22 Gevaert Photo Producten Naamlo Improvements in and relating to cyanine and styryl dyestuffs or dye bases and to thepreparation thereof and to photographic emulsions containing the same
US2890982A (en) * 1956-10-30 1959-06-16 Norwich Pharma Co Method of combatting helminthiasis using nitro-furyl-acrylate derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2534237A (en) * 1950-12-19 B-haloxanthine salts of aminoalkyl
US1994170A (en) * 1930-09-20 1935-03-12 Agfa Ansco Corp Compound of the distyryl pyridinium salt series and its production
GB656515A (en) * 1947-04-02 1951-08-22 Gevaert Photo Producten Naamlo Improvements in and relating to cyanine and styryl dyestuffs or dye bases and to thepreparation thereof and to photographic emulsions containing the same
US2890982A (en) * 1956-10-30 1959-06-16 Norwich Pharma Co Method of combatting helminthiasis using nitro-furyl-acrylate derivatives

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
WO2004078136A3 (en) * 2003-03-03 2004-12-16 Mycosol Inc Pyridinium salts, compounds and methods of use
US7220761B2 (en) 2003-03-03 2007-05-22 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects
JP2007525441A (ja) * 2003-03-03 2007-09-06 マイコソル,インコーポレイテッド ピリジニウム塩、化合物および使用法
US7547444B1 (en) 2003-03-03 2009-06-16 Mycosol, Inc. Methods for controlling fungi and bacteria
US7820696B2 (en) 2003-03-03 2010-10-26 Mycosol, Inc. Compounds and methods for controlling fungi, bacteria and insects
US8124626B2 (en) 2003-03-03 2012-02-28 Mycosol, Inc. Methods of treating inflammations and infections with pyridinium salts
WO2007056556A3 (en) * 2005-11-08 2007-10-25 Mycosol Inc Polyethylene glycol conjugates of pyridinium and thiazolium compounds and methods of using the same
US20110053987A1 (en) * 2005-11-08 2011-03-03 Selph Jeffrey L Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same
US8247571B2 (en) * 2005-11-08 2012-08-21 Mycosol, Inc. Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same
US20130281392A1 (en) * 2012-04-20 2013-10-24 Merial Limited Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
US9000187B2 (en) * 2012-04-20 2015-04-07 Merial, Inc. Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

Also Published As

Publication number Publication date
SE217920C1 (de) 1968-01-02
DK104234C (da) 1966-04-25
FR1841M (fr) 1963-06-04
NL277327A (de)
CH413836A (de) 1966-05-31
LU41596A1 (de) 1962-10-22
GB1009301A (en) 1965-11-10
OA02352A (fr) 1970-05-05
MY6700093A (en) 1967-12-31
ES276612A1 (es) 1962-08-01
BR6238334D0 (pt) 1973-05-17
DE1470413A1 (de) 1969-07-17

Similar Documents

Publication Publication Date Title
DE2635276A1 (de) Tetrahydroisochinolin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
Weisblat et al. The Cleavage of Sulfonamides1
DE3834861A1 (de) Arylalkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
EHRLICH et al. Experiments in the veratrole and quinoxaline groups
EP0005232A1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
US3075975A (en) Anthelmintic distilbazoles and method
GB2058073A (en) 8-aminoalkyl-4-alkylpsoralens
DE1545575B1 (de) N,N'-Bis-[3-(3',4',5'-trimethoxybenzoyloxy)-propyl]-homopiperazin
O'BRIEN et al. Amino derivatives of Kojic acid
US3166562A (en) Novel nicotinic acid phenyl-ethylamides and process for preparing them
DE1593762A1 (de) Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
DE2000775A1 (de) Substituierte 1,2,3,4-Tetrahydrobenzothieno-[2,3-c]-pyridinderivate und Verfahren zu deren Herstellung
McCoubrey et al. 148. Contributions to the chemistry of iso quinolines. Part I. The synthesis of diamino-1-phenylisoquinoline methiodides in a search for new trypanocides, with some observations on the nitration of 1-phenylisoquinoline
Lee et al. Reactivity of quinone imine and quinone diimine metabolites of the antitumor drug amsacrine and related compounds to nucleophiles
US2956072A (en) N-(1-naphthyl)-n'-(beta-substituted ethyl)-ureas
Birosel Phenolic Decomposition of Certain Mixed Ethers. II. The Effect of Substitution. The Rate Constant
US2471622A (en) Mercury compounds and process of preparing same
US3090788A (en) Substituted isoxazole carboxamide compounds
US2681911A (en) 1, 2, 3, 4-tetrahydroisoquinolinalkanol esters of aromatically substituted aliphaticacids and their derivatives
DE2318575A1 (de) Neue oxazolidinone
US2775595A (en) Chzohz
Walls 13. Researches in the phenanthridine series. Part VIII. Further investigation of trypanocidal types
US2480367A (en) Manufacture of therapeutic substances
US2168929A (en) Isoquinoline compounds and derivatives thereof
CH553193A (en) Prepn of 1 4-benzodiazepine 4-oxides from novel oximes